Martin Holst Lange

Executive Vice President, R&D and Chief Scientific Officer · Novo Nordisk

Pharmaceuticals

Martin Holst Lange leads Novo Nordisk’s research and development as chief scientific officer, following clinical work and leadership of diabetes drug development.

Last reviewed: Nov 15, 2026

Executive Summary

Martin Holst Lange leads Novo Nordisk’s research and development as chief scientific officer, following clinical work and leadership of diabetes drug development.

Career Highlights

  • Joined Novo Nordisk in 2002 after clinical work and endocrinology research.
  • Led global development from 2018 and became an executive vice president in 2021.
  • Took responsibility for the combined R&D organisation in August 2025.

Professional Journey

Lange worked in clinical practice and research from 1997 to 2002, including three years in endocrinology research at Denmark’s National University Hospital. He joined Novo Nordisk in 2002, initially taking operational and then medical responsibility for development projects involving growth hormone, GLP-2 and oral diabetes treatments.

From 2006 to 2008, he worked in the United States as a senior medical director at Novo Nordisk Inc. He returned to Denmark in 2008 to lead medical and science work on liraglutide during its submission and approval phase. Following Victoza’s US approval in 2010, he moved to insulin degludec in a similar role.

Between 2013 and 2017, Lange held corporate project vice president positions covering insulin, diabetes outcomes and devices. He became senior vice president of Global Development in January 2018, assuming overall responsibility for clinical development across the pipeline, and executive vice president of Development in March 2021.

In August 2025, Novo Nordisk combined Research and Early Development with Development under Lange as chief scientific officer. His responsibilities consequently expanded from clinical development to the consolidated R&D organisation. He earned his medical degree in 1997 and an endocrinology doctorate in 2004, both at the University of Copenhagen.

Education

  • University of Copenhagen — M.D., Medicine.
  • University of Copenhagen — Ph.D., Endocrinology.